Evaluation of serum high-density lipoprotein cholesterol levels as a prognostic factor in gastric cancer patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 10, 2012, Pages 1635-1640

  Tamura, Takafumi ^a   Inagawa, Satoshi ^a   Hisakura, Katsuji ^a   Enomoto, Tsuyoshi ^a   Ohkohchi, Nobuhiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Gastric cancer; High density lipoprotein cholesterol; Hyperlipidemia; Metabolic syndrome

Indexed keywords

ANTINEOPLASTIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER;

EID: 84866534694     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07189.x     Document Type: Article

References (34)

1. Greenlee RT, Hill-Harman MB, Taylor Murray T, Thun M. Cancer statistics, 2001. CA Cancer J. Clin. 2001; 51: 15-36.
2. World Health Organization. Fact Sheet N 297. Cited 23 June 2012. Available from URL: http://www.who.int/mediacentre/factsheets/fs297/
3. Meyer HJ, Jahne J. Lymph node dissection for gastric cancer. Semin. Surg. Oncol. 1999; 17: 117-24.
4. Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat. Rev. 2000; 26: 243-55.
5. Sasako M, Saka M, Fukagawa T, Katai H, Sano T. Surgical treatment of advanced gastric cancer: Japanese perspective. Dig. Surg. 2007; 24: 101-7.
6. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010; 11: 439-49.
7. Samson PS, Escovidal LA, Yrastorza SG, Veneracion RG, Nerves MY. Re-study of gastric cancer: analysis of outcome. World J. Surg. 2002; 26: 428-33.
8. Bonnenkamp JJ, Hermans J, Sasako M etal. Extended lymph-node dissection for gastric cancer. N. Engl. J. Med. 1999; 340: 908-14.
9. Cunningham D, Allum WH, Stenning SP etal. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med. 2006; 355: 11-20.
10. Sakuramoto S, Sasako M, Yamaguchi T etal. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N. Engl. J. Med. 2007; 357: 1810-20.
11. Jafri H, Alsheikh-Ali AA, Karas RH. Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J. Am. Coll. Cardiol. 2010; 55: 2846-54.
12. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003; 348: 1625-38.
13. Adams KF, Schatzkin A, Harris TB etal. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71years old. N. Engl. J. Med. 2006; 355: 763-78.
14. Michalaki V, Koutroulis G, Syrigos K, Piperi C, Kalofoutis A. Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol. Cell. Biochem. 2005; 268: 19-24.
15. Gaziano JM, Hennekens CH. Dietary fat and risk of prostate cancer. J. Natl. Cancer Inst. 1995; 87: 1427-8.
16. van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M etal. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 2011; 60: 1094-102.
17. Tornberg SA, Carstensen JM, Holm LE. Risk of stomach cancer in association with serum cholesterol and beta-lipoprotein. Acta Oncol. 1988; 27: 39-42.
18. Kitayama J, Hatano K, Kaisaki S, Suzuki H, Fujii S, Nagawa H. Hyperlipidaemia is positively correlated with lymph node metastasis in men with early gastric cancer. Br. J. Surg. 2004; 91: 191-8.
19. Guo E, Chen L, Xie Q, Chen J, Tang Z, Wu Y. Serum HDL-C as a potential biomarker for nodal stages in gastric cancer. Ann. Surg. Oncol. 2007; 14: 2528-34.
20. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual, 7th edn. New York: Springer, 2009.
21. Adachi Y, Mori M, Kido A, Shimono R, Maehara Y, Sugimachi K. A clinicopathologic study of mucinous gastric carcinoma. Cancer 1992; 69: 866-71.
22. National Institutes of Health, National Heart, Lung and Blood Institute. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, andTreatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
23. Grundy SM, Cleeman JI, Daniels SR etal. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52.
24. Redig AJ, Munshi HG. Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy. Am. J. Med. 2010; 123: 87.e1-6.
25. Alexopoulos CG, Blatsios B, Avgerinos A. Serum lipids and lipoprotein disorders in cancer patients. Cancer 1987; 60: 3065-70.
26. Fiorenza AM, Branchi A, Sommariva D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int. J. Clin. Lab. Res. 2000; 30: 141-5.
27. Howe GR, Aronson KJ, Benito E etal. The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies. Cancer Causes Control 1997; 8: 215-28.
28. Slotte JP. HDL receptors and cholesterol efflux from parenchymal cells. Eur. Heart J. 1990; 11: 212-17.
29. Eisenberg S. High density lipoprotein metabolism. J. Lipid Res. 1984; 25: 1017-58.
30. Nozoe T, Iguchi T, Egashira A, Adachi E, Matsukuma A, Ezaki T. Pathological prognostic score as a simple criterion to predict outcome in gastric carcinoma. J. Surg. Oncol. 2010; 102: 73-6.
31. Makino T, Shukla PJ, Rubino F, Milsom JW. The impact of obesity on perioperative outcomes after laparoscopic colorectal resection. Ann. Surg. 2012; 255: 228-36.
32. Inagawa S, Adachi S, Oda T, Kawamoto T, Koike N, Fukao K. Effect of fat volume on postoperative complications and survival rate after D2 dissection for gastric cancer. Gastric Cancer 2000; 27: 141-4.
33. Tsujinaka T, Sasako M, Yamamoto S etal. Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501). Ann. Surg. Oncol. 2007; 14: 355-61.
34. Dhar DK, Kubota H, Tachibana M etal. Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patients. Oncology 2000; 59: 18-23.